Paxil Suicide Cases
Paxil Suicide Cases and Information. Call Today for a Consulatation.
Paxil is an antidepressant medication that was created by the pharmaceutical company GlaxoSmithKline in 1992. In addition to being prescribed for depression, Paxil can also be prescribed for anxiety disorders. Since it’s release, it has become one of the most prescribed antidepressants on the market. However, its effectiveness has come into question due to the rising amount of Paxil suicide cases that have come up since its release.
A Paxil related suicide is a major risk for anyone currently taking the medication. Those who stop taking it cold turkey are at an even higher risk for falling subject to a number of harmful situations including suicide. A 2004 Paxil suicide cases study conducted in Britain, found patients taking Paxil were actually four times more likely to develop suicidal behaviors compared to a control group of participants who hadn’t taken this potentially dangerous SSRI antidepressant.
If you or someone you know has suffered through Paxil suicide cases, we may be able to help you. We have helped families just like yours who have gone through the wrongful death of a loved one.
In late 2004, attorney Andy Vickery went before the FDA Advisory Committee and helped establish the truth behind Paxil suicide cases. As a result from his testimony and countless others, the FDA admitted that causality has been established between SSRI drugs like Zoloft, Paxil and Prozac in pediatric suicides. By a vote of 15-8, black box warnings will be placed on the labels of these and other antidepressants.
Contact us today and we will look into how we can help protect and maximize your interests. For more information on Paxil suicide cases, take a look at our documented cases page for an in depth look on how we are able to help you.
Progress in Paxil Suicide Cases
In March of 2005, the FDA in conjunction with the Department of Justice seized Paxil CR and Avandamet tablets manufactured by GlaxoSmithKline, Inc. This was conducted because manufacturing practices regarding these two drugs failed to meet the FDA’s quality guidelines. Click to Read More
In October of 2004, the FDA launched a new strategy to warn the public about the increased risk of suicidal thoughts and behavior in children and adolescents who are being treated with antidepressant medications. Click To Learn More
In June of 2003, following a verdict in a case represented by Vickery & Waldner, the FDA announced that Paxil, an antidepressant drug, should not be given to children under the age of 18 because of an increased risk of suicide. Click To Learn More
Contact Us Today
| | © 2008, Justice Seekers. All rights reserved. |
| 
